Product Information
XGEVA 120 MG/1.7 ML VIAL is a brand product labeled by Amgen Inc., priced at $2001.5168 per ML under NDC 55513073021. Its NADAC has been published 27 times since Dec 24, 2025.
Strength
120 mg/1.7mL
Manufacturer
Amgen Inc.NDC
55513073021
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
1/7/2026
Active Ingredients
DENOSUMABApproval Type
Biologic (BLA)
FDA Application
BLA125320On Market Since
11/18/2010
Pharmacological Classes
Price Statistics
The NADAC for XGEVA 120 MG/1.7 ML VIAL has been published 27 times since Dec 24, 2025, and over the history we have for it it has risen 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2001.5168 per ML |
|---|---|
| All-time high | $2001.5168 (Jun 24, 2026) |
| All-time low | $1943.2202 (Dec 24, 2025) |
| 52-week high | $2001.5168 |
| 52-week low | $1943.2202 |
| Median price | $2001.5168 |
| Average price | $1995.0394 |
| Largest weekly change | +3.0% (Jan 14, 2026) |
| Weeks tracked | 27 |
| Tracking since | Dec 24, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of XGEVA 120 MG/1.7 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for XGEVA 120 MG/1.7 ML VIAL, manufactured by Amgen Inc., is $2001.5168 per ML (NDC 55513073021), effective Jun 24, 2026.
How has the price of XGEVA 120 MG/1.7 ML VIAL changed over time?
Over the history we have for it, the NADAC for XGEVA 120 MG/1.7 ML VIAL has risen 3.0%. It has been tracked across 27 weekly CMS publications since Dec 24, 2025.
What are the highest and lowest recorded NADAC prices for XGEVA 120 MG/1.7 ML VIAL?
Since Dec 24, 2025, the NADAC for XGEVA 120 MG/1.7 ML VIAL has ranged from a low of $1943.2202 (Dec 24, 2025) to a high of $2001.5168 (Jun 24, 2026), with a median of $2001.5168 per ML.
Are there cheaper alternatives to XGEVA 120 MG/1.7 ML VIAL?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as XGEVA 120 MG/1.7 ML VIAL, but none are currently priced below it.
Who manufactures XGEVA 120 MG/1.7 ML VIAL?
XGEVA 120 MG/1.7 ML VIAL (NDC 55513073021) is labeled by Amgen Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification